[Action and molecular targets of anti cancer agents from microbial products].
Ishizuka
M
M
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D001578:Benzopyrans / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects*; D009369:Neoplasms / Q000473:pathology; D010755:Organophosphates / Q000494:pharmacology*; D011753:Pyrones / Q000494:pharmacology*; D012694:Serine / Q000031:analogs & derivatives* / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000903:Antibiotics, Antineoplastic; D001578:Benzopyrans; D010755:Organophosphates; D011753:Pyrones; C069645:conagenin; C088526:cytostatin; D012694:Serine; C025268:bactobolin